NanoLogix readies FDA applications for rapid bacteria tests
Diagnostics company NanoLogix (OTCBB:NNLX) is preparing several U.S. Food and Drug Administration applications for its rapid bacteria-testing technology. NanoLogix said the applications will include results of tests that examined the company’s technology in detecting tuberculosis and Group B Streptococcus, according to a statement from the Hubbard, Ohio-based company. The company’s technology involves a proprietary water-permeable […]